1. Home
  2. ATHE vs WISA Comparison

ATHE vs WISA Comparison

Compare ATHE & WISA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • WISA
  • Stock Information
  • Founded
  • ATHE 1997
  • WISA 2010
  • Country
  • ATHE Australia
  • WISA United States
  • Employees
  • ATHE N/A
  • WISA N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • WISA Semiconductors
  • Sector
  • ATHE Health Care
  • WISA Technology
  • Exchange
  • ATHE Nasdaq
  • WISA Nasdaq
  • Market Cap
  • ATHE 10.1M
  • WISA 9.9M
  • IPO Year
  • ATHE N/A
  • WISA 2018
  • Fundamental
  • Price
  • ATHE $1.07
  • WISA $1.73
  • Analyst Decision
  • ATHE Buy
  • WISA Strong Buy
  • Analyst Count
  • ATHE 1
  • WISA 1
  • Target Price
  • ATHE $4.00
  • WISA $14.00
  • AVG Volume (30 Days)
  • ATHE 13.7K
  • WISA 442.1K
  • Earning Date
  • ATHE 12-03-2024
  • WISA 11-15-2024
  • Dividend Yield
  • ATHE N/A
  • WISA N/A
  • EPS Growth
  • ATHE N/A
  • WISA N/A
  • EPS
  • ATHE N/A
  • WISA N/A
  • Revenue
  • ATHE $2,681,669.00
  • WISA $2,192,000.00
  • Revenue This Year
  • ATHE N/A
  • WISA N/A
  • Revenue Next Year
  • ATHE N/A
  • WISA $207.69
  • P/E Ratio
  • ATHE N/A
  • WISA N/A
  • Revenue Growth
  • ATHE 2.63
  • WISA N/A
  • 52 Week Low
  • ATHE $1.00
  • WISA $1.15
  • 52 Week High
  • ATHE $5.41
  • WISA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 37.45
  • WISA 42.88
  • Support Level
  • ATHE $1.05
  • WISA $1.73
  • Resistance Level
  • ATHE $1.13
  • WISA $2.40
  • Average True Range (ATR)
  • ATHE 0.07
  • WISA 0.16
  • MACD
  • ATHE -0.01
  • WISA -0.01
  • Stochastic Oscillator
  • ATHE 23.88
  • WISA 4.93

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About WISA WiSA Technologies Inc.

WiSA Technologies Inc is a provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems through the sale of module components to audio companies as well as audio products to resellers and consumers.. The company works with consumer electronics companies, technology providers, retailers, and ecosystem partners to make immersive audio an enjoyable experience. The company has a geographic presence in Asia Pacific, North America, Europe and, other.

Share on Social Networks: